TWENTY-FIVE PHARMACEUTICAL DOSAGE FORMS IN PHARMACOLOGY AND CLINICAL PHARMACY: TECHNOLOGICAL DEVELOPMENT, PHARMACOKINETICS, BIOAVAILABILITY, AND CLINICAL APPLICATION
Keywords:
pharmaceutical dosage forms, drug delivery systems, pharmacokinetics, bioavailability, clinical pharmacy, controlled release, parenteral administration, transdermal delivery, inhalation therapy, implants.Abstract
Pharmaceutical dosage forms are a fundamental component of modern pharmacology and clinical pharmacy because they determine not only the technological characteristics of a medicinal product but also its pharmacokinetic behavior, bioavailability, onset and duration of action, safety profile, and suitability for individual patients. The purpose of this study was to provide an integrative analysis of twenty-five commonly used pharmaceutical dosage forms with emphasis on their technological preparation, pharmacokinetic properties, bioavailability, and clinical applicability. The study was conducted as a descriptive and comparative review of pharmaceutical and pharmacological literature. Dosage forms were classified according to route of administration, physical state, release characteristics, and therapeutic purpose. The analysis included conventional tablets, enteric-coated tablets, controlled-release tablets, hard and soft gelatin capsules, powders, granules, lozenges, dragees, oral solutions, syrups, suspensions, emulsions, ointments, creams, gels, pastes, rectal suppositories, vaginal pessaries, injectable solutions, injectable suspensions, infusion solutions, inhalation aerosols, transdermal patches, and implants. The findings demonstrate that dosage form selection substantially influences drug absorption, first-pass metabolism, systemic availability, local versus systemic action, duration of effect, dosing frequency, and patient adherence. Oral solid dosage forms remain convenient and widely used, whereas parenteral forms provide the most rapid and complete systemic availability. Topical and mucosal forms are particularly valuable for localized therapy, while modified-release, transdermal, inhalational, and implantable systems offer important advantages in sustained or targeted drug delivery. The appropriate pharmaceutical form should therefore be selected according to the physicochemical characteristics of the drug, therapeutic objective, patient age, disease condition, required onset of action, duration of treatment, and adherence considerations.
References
1.Allen LV, Popovich NG, Ansel HC. Ansel’s Pharmaceutical Dosage Forms and Drug Delivery Systems. 10th ed. Philadelphia: Lippincott Williams & Wilkins; 2013.
2.European Medicines Agency. List of Pharmaceutical Dosage Forms. 2023.
3.Brunton LL, Hilal-Dandan R, Knollmann BC, eds. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 13th ed. New York: McGraw-Hill; 2018.
4.Janczura M, et al. The development of innovative dosage forms of fixed-dose combinations. Pharmaceutics. 2022.
5.Mahato RI, Narang AS. Pharmaceutical Dosage Forms and Drug Delivery. 3rd ed. Boca Raton: CRC Press; 2018.
6.Nematilloyevna KM. The easy ways of learning medical plants (phytonyms) in the Department of Pharmaceutical Terminology. JournalNX. 7(06):274–277.
7.Nematilloyevna XM. Farmatsevtik terminologiyada ma’noli qismlar. Modern Education and Development. 2024;16(9):232–243.
8.Obidov OO, Musayeva NA, Ismatova ShSh. Umumiy farmakologiya va retseptura: o‘quv qo‘llanma. Tashkent: Ilm-Ziyo; 2013.
9.Adejare A, ed. Remington: The Science and Practice of Pharmacy. 23rd ed. Philadelphia: Elsevier; 2021.
10.Xaydarov VR, Tadjieva AD, Usubbaev AM, et al. Farmatsevtik texnologiya (tayyor dori turlari texnologiyasi). Tashkent: Ibn Sino; 2022.
11.Khafizova M. Простые способы изучения лекарственных растений (фитонимов) в разделе фармацевтической терминологии. Central Asian Journal of Education and Innovation. 2023;2(11 Part 2):193–198.
12.Khafizova M. Studing medicinal plants (phytonyms) in the section of pharmaceutical terminology. Central Asian Journal of Multidisciplinary Research and Management Studies. 2024;1(2):4–7.
13.Khafizova M. The use of segments of frequency in the names of medicines in pharmaceutical terminology. Modern Science and Research. 2025;4(2):708–714.
14.Shargel L, Yu ABC, Wu-Pong S, et al. Applied Biopharmaceutics & Pharmacokinetics. 8th ed. New York: McGraw-Hill; 2022.
15.Ministry of Health of the Republic of Uzbekistan. Law on Medicinal Products and Pharmaceutical Activities, No. 415-I, 25 April 1997, as amended.
